menu
    • menu

    Company profile for Astrocyte Pharmaceuticals

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Astrocyte Pharmaceuticals is pursuing an innovative neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. This enables selective activation of their caretaker processes including the removal of harmful extracellular molecules and the restoration of ion homeostasis. The company is investigating and advancing small molecule pharmaceutical medicines

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Astrocyte PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    93 Shennecossett Road, Groton, CT 06340
    Telephone
    Telephone
    +1 617-444-8765
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.astrocytepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astrocyte Pharmaceuticals Hits Milestones: Phase 2 Trial, $3M NIH
    Astrocyte Pharmaceuticals Hits Milestones: Phase 2 Trial, $3M NIH

    17 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/17/3100467/0/en/Astrocyte-Pharmaceuticals-Announces-Milestones-in-the-Fight-Against-Concussions-Launch-of-Phase-2-Clinical-Trial-and-New-3M-NIH-Grant.html

    GLOBENEWSWIRE
    17 Jun 2025
    Share Share
    Astrocyte Announces FDA Clearance of its Investigational NDA for AST-004
    Astrocyte Announces FDA Clearance of its Investigational NDA for AST-004

    12 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/12/2844784/0/en/Astrocyte-Pharmaceuticals-Announces-FDA-Clearance-of-its-Investigational-New-Drug-Application-for-AST-004.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Alzheimer's Drug Discovery Foundation Joins Astrocyte’s $6M Financing Round
    Alzheimer's Drug Discovery Foundation Joins Astrocyte’s $6M Financing Round

    18 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230818032516/en

    BUSINESSWIRE
    18 Aug 2023
    Share Share
    Astrocyte Announces Theodore Liston, Ph.D., Vice President of Research
    Astrocyte Announces Theodore Liston, Ph.D., Vice President of Research

    10 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230410005135/en

    BUSINESSWIRE
    10 Apr 2023
    Share Share
    Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004
    Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004

    05 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230405005629/en

    BUSINESSWIRE
    05 Apr 2023
    Share Share
    Astrocyte Pharma Presents Update on AST-004 Clinical Program at 2022 Symposium
    Astrocyte Pharma Presents Update on AST-004 Clinical Program at 2022 Symposium

    14 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220914005969/en

    BUSINESSWIRE
    14 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search